About the Company
Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TECH News
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
Dx, a molecular diagnostics company, are pleased to announce the development of Bio-Marker Pathfinder (BMP), a first of its kind ocular biomarker kit, as a point-of-care application. Novomol-Dx is a ...
Bio-Techne Corp (TECH) Stock: Navigating the Market Volatility
Bio-Techne Corp (NASDAQ: TECH) has a price-to-earnings ratio that is above its average at 45.80x. The stock has a 36-month beta value of 1.23. Opinions on the stock are mixed, with 2 analysts rating ...
Which Is a Better Investment, Janux Therapeutics Inc or BIO-TECHNE Corp Stock?
Learn more about whether Janux Therapeutics Inc or BIO-TECHNE Corp is a better investment based on AAII's A+ Investor grades, ...
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced that it ...
Navigating 4 Analyst Ratings For Bio-Techne
In the preceding three months, 4 analysts have released ratings for Bio-Techne (NASDAQ:TECH), presenting a wide array of ...
A Data-Based Look At Bio-Techne Corp (TECH)
Having a second look at Bio-Techne Corp (NASDAQ:TECH) provides that stock’s average daily trading volume for 3 months was 1.08 million, while it jumped to 0.95 million when we calculate an average ...
Bio-Techne loses UK patent bid and heads to UPC
UK High Court invalidates two patents due to “overwhelming evidence” supplied by defendant | Biotech firm files same claims ...
Nvidia and AMD stand out on this new list of Wall Street’s 20 favorite stocks
Nvidia remains on the list. However, the 12-month implied upside for the stock, based on the consensus price target, is “only ...
Glycobiology Market Shaping Strategies How Focus Groups Influence Qualitative Research Outcomes
Glycobiology Market is valued approximately at USD 1.04 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 14.64 % over the forecast period 2020-2027. Glycobiology is ...
AGW-Mental Wellbeing 2024 - Mid-size companies
America's Greatest Workplaces for Mental Wellbeing 2024. Mental well-being is an increasingly important concern for U.S. workers—which means it's increasingly important for U.S.
Cryopreservation Media Market Overview, Size, Share, Trends, Demand, Research, and Forecast 2024 to 2032
Cryopreservation Media Market is valued approximately USD $ Billion in 2019 and is anticipated to grow with a healthy growth ...
Which Is a Better Investment, Celldex Therapeutics, Inc. or BIO-TECHNE Corp Stock?
Learn more about whether Celldex Therapeutics, Inc. or BIO-TECHNE Corp is a better investment based on AAII's A+ Investor ...
Loading the latest forecasts...